These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

394 related items for PubMed ID: 32029478

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Molecular binding response of naringin and naringenin to H46R mutant SOD1 protein in combating protein aggregation using density functional theory and discrete molecular dynamics.
    Srinivasan E, Rajasekaran R.
    Prog Biophys Mol Biol; 2019 Aug; 145():40-51. PubMed ID: 30543828
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Therapeutic vaccines for amyotrophic lateral sclerosis directed against disease specific epitopes of superoxide dismutase 1.
    Zhao B, Marciniuk K, Gibbs E, Yousefi M, Napper S, Cashman NR.
    Vaccine; 2019 Aug 14; 37(35):4920-4927. PubMed ID: 31324499
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Perspective on SOD1 mediated toxicity in Amyotrophic Lateral Sclerosis.
    Sangwan S, Eisenberg DS.
    Postepy Biochem; 2016 Aug 14; 62(3):362-369. PubMed ID: 28132491
    [Abstract] [Full Text] [Related]

  • 51. Functional links between SQSTM1 and ALS2 in the pathogenesis of ALS: cumulative impact on the protection against mutant SOD1-mediated motor dysfunction in mice.
    Hadano S, Mitsui S, Pan L, Otomo A, Kubo M, Sato K, Ono S, Onodera W, Abe K, Chen X, Koike M, Uchiyama Y, Aoki M, Warabi E, Yamamoto M, Ishii T, Yanagawa T, Shang HF, Yoshii F.
    Hum Mol Genet; 2016 Aug 01; 25(15):3321-3340. PubMed ID: 27439389
    [Abstract] [Full Text] [Related]

  • 52. Pathogenicity classification of SOD1 variants of uncertain significance by in vitro aggregation propensity.
    Chen LX, Xu HF, Lin HX, Yang XX, Li HF, Wu ZY.
    Neurobiol Aging; 2023 Mar 01; 123():182-190. PubMed ID: 36376198
    [Abstract] [Full Text] [Related]

  • 53. A hyperthermophilic protein G variant engineered via directed evolution prevents the formation of toxic SOD1 oligomers.
    Dagan B, Oren O, Banerjee V, Taube R, Papo N.
    Proteins; 2019 Sep 01; 87(9):738-747. PubMed ID: 31017342
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. p62 accumulates and enhances aggregate formation in model systems of familial amyotrophic lateral sclerosis.
    Gal J, Ström AL, Kilty R, Zhang F, Zhu H.
    J Biol Chem; 2007 Apr 13; 282(15):11068-77. PubMed ID: 17296612
    [Abstract] [Full Text] [Related]

  • 60. Superoxide dismutase 1 encoding mutations linked to ALS adopts a spectrum of misfolded states.
    Prudencio M, Borchelt DR.
    Mol Neurodegener; 2011 Nov 17; 6():77. PubMed ID: 22094223
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.